Sequential endoluminal gemcitabine and docetaxel vs. Bacillus Calmette–Guérin for the treatment of upper tract carcinoma in situ

Overview of attention for article published in Urologic Oncology, April 2024

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (74th percentile)
Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

twitter: 8 X users

Readers on

mendeley: 7 Mendeley

So far, Altmetric has seen 8 X posts from 8 X users, with an upper bound of 22,533 followers.

RT @ryansteinbergmd: 💥JUST PUBLISHED💥 Gem/Doce vs BCG for Upper Tract CIS 📍54% vs 61% 2 year RFS 📍100% vs 89% 2 year NephU-FS 📍HR 3.89 if…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 4 additional X posts.